Date & Location
Wednesday, October 6, 2021, 6:00 PM - 7:30 PM EST, Online, Philadelphia, PA
Course Overview
Join us Wednesday, October 6, 2021, at 6PM ET for a live, virtual 1.5-hour CME, discussing the surgical and medical management of drug-resistant epilepsy.
During the activity, the presenters will review two neurology cases, as well as two surgical epilepsy cases. Each case will be specific to the treatment of adult patients with epilepsy, whose diseases have been resistant to medication. The four cases will provide a review of current medical and surgical practices and will highlight technological advances in monitoring and treating seizures and epilepsy.
Following the case discussion, Drs. Davis and Gelfand will review the qualifications and process for referring patients to a Level 4 Epilepsy Center.
Epilepsy-related disorders can cause recurrent seizures that can occur without warning. Management of drug-resistant epilepsy requires comprehensive, individualized evaluation and advanced facilities. This discussion will highlight a variety of treatments offered at the Penn Epilepsy Center and conclude with a Q&A panel.
Target Audience
Specialties - FAMILY MEDICINE, INTERNAL MEDICINE, NEUROLOGICAL SURGERY, NEUROLOGY, OBSTETRICS AND GYNECOLOGY, PSYCHIATRY AND NEUROLOGY - Epilepsy
Professions - Nurse Practitioners, Other Healthcare Professionals, Physician Assistants, Physicians
Objectives
After completing this activity, participants should be able to:
- Discuss the latest information in drug-resistant epilepsy treatment
- Describe advances in clinical and surgical treatment of epilepsy
- Identify the gaps in treatment that exist for patients with recurrent attacks when medication fails
- Recognize the impact of video monitoring in diagnosis and treatment of patients with recurrent seizures that are resistant to medication
- Determine when to send patients to a Level 4 Epilepsy Center
Accreditation
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Penn Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credits
AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance / Participation (1.50 hours), ABIM MOC Part 2 (1.50 hours)
BROADCASTMED